Clinical value of FDG-PET for preoperative evaluation of endometrial cancer

Annals of Nuclear Medicine

Volumn 25, Issue 4, 2011, Pages 269-275

  Suga, Tsuyoshi ^a   Nakamoto, Yuji ^a   Saga, Tsuneo ^b   Higashi, Tatsuya ^a   Hamanaka, Yasuyo ^c   Tatsumi, Mitsuaki ^c   Hayashida, Kohei ^c   Hara, Tadashi ^a   Konishi, Ikuo ^a   Fujii, Shingo ^d   Togashi, Kaori ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c Takeda Oncologic Positron Imaging Center   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

Endometrial cancer; FDG PET; Preoperative evaluation

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; MEDROXYPROGESTERONE ACETATE;

ADENOMYOSIS; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENDOMETRIUM CANCER; ENDOMETRIUM POLYP; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LEIOMYOMA; LUNG METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; METASTASIS; MIXED TUMOR; MUCINOUS CARCINOMA; MYOMECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SENSITIVITY AND SPECIFICITY; SMALL CELL CARCINOMA; TUMOR BIOPSY; WHOLE BODY PET;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES;

EID: 79959958713     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-011-0474-2     Document Type: Article

References (21)

1. Manfredi R, Mirk P, Maresca G, Margariti PA, Testa A, Zannoni GF, et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology. 2004; 231: 372-8. (Pubitemid 38552891)
2. Koyama T, Tamai K, Togashi K. Staging of carcinoma of the uterine cervix and endometrium. Eur Radiol. 2007; 17: 2009-19. (Pubitemid 47097458)
3. Rockall AG,MeroniR, Sohaib SA, Reynolds K, Alexander-Sefre F, Shepherd JH, et al. Evaluation of endometrial carcinoma on agnetic resonance imaging. Int J Gynecol Cancer. 2007; 17: 188-96. (Pubitemid 46213990)
4. Connor JP, Andrews JI, Anderson B, Buller RE. Computed tomography in endometrial carcinoma. Obstet Gynecol. 2000; 95: 692-6. (Pubitemid 30210053)
5. Horowitz NS, Dehdashti F, Herzog TJ, Rader JS, Powell MA, Gibb RK, et al. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol. 2004; 95: 546-51. (Pubitemid 39592519)
6. Suzuki R, Miyagi E, Takahashi N, Sukegawa A, Suzuki A, Koike I, et al. Validity of positron emission tomography using fluoro-2- deoxyglucose for the preoperative evaluation of endometrial cancer. Int J Gynecol Cancer. 2007; 17: 890-6. (Pubitemid 47063323)
7. 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer. Am J Roentgenol. 2008; 190: 1652-8. (Pubitemid 351798544)
8. Saga T, Higashi T, Ishimori T, Mamede M, Nakamoto Y, Mukai T, et al. Clinical value of FDG-PET in the follow up of postoperative patients with endometrial cancer. Ann Nucl Med. 2003; 17: 197-203. (Pubitemid 36834431)
9. Kitajima K, Murakami K, Yamasaki E, Hagiwara S, Fukasawa I, Inaba N, et al. Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer. Ann Nucl Med. 2008; 22: 103-9. (Pubitemid 351328965)
10. Ayhan A, Tuncer R, Tuncer ZS, Yü ce K, Küçükali T. Correlation between clinical and histopathologic risk factors and lymph node metastases in early endometrial cancer (a multivariate analysis of 183 cases). Int J Gynecol Cancer. 1994; 4: 306-9.
11. Jobo T, Sato R, Arai T, Tamura T, Watanabe J, Kuramoto H. Lymph node pathway in the spread of endometrial carcinoma. Eur J Gynecol Oncol. 2005; 26: 167-9. (Pubitemid 40546525)
12. Bristow RE, Zahurak ML, Alexander CJ, Zellars RC, Montz FJ. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int J Gynecol Cancer. 2003; 13: 664-72.
13. Candiani GB, Belloni C, Maggi R, Colombo G, Frigoli A, Carinelli SG. Evaluation of different surgical approaches in the treatment of endometrial cancer at FIGO stage I. Gynecol Oncol. 1990; 37: 6-8. (Pubitemid 20147960)
14. Bar-Am A, Ron IG, Kuperminc M, Gal I, Jaffa A, Kovner F, et al. The role of routine pelvic lymph node sampling in patients with stage I endometrial carcinoma: second thoughts. Acta Obstet Gynecol Scand. 1998; 77: 347-50. (Pubitemid 28120912)
15. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000; 182: 1506-19. (Pubitemid 30437424)
16. Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, et al. Retrospective analysis of selective ymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005; 23: 3668-75.
17. Kasamatsu T, Onda T, Katsumata N, Sawada M, Yamada T, Tsunematsu R, et al. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer. 2003; 88: 245-50. (Pubitemid 36255843)
18. Ebina Y, Hareyama H, Sakuragh N, Yamamoto R, Furuya M, Sogame M, et al. Peritoneal cytology and its prognostic value in endometrial carcinoma. Int Surg. 1997; 82: 244-8. (Pubitemid 27482993)
19. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009; 105: 109.
20. Goff BA, Goodman A, Muntz HG, Fuller AF Jr, Nikrui N, Rice LW. Surgical stage IV endometrial carcinoma: a study of 47 cases. Gynecol Oncol. 1994; 52: 237-40. (Pubitemid 24064377)
21. Chi DS, Welshinger M, Venkatraman ES, Barakat RR. The role of surgical cytoreduction in Stage IV endometrial carcinoma. Gynecol Oncol. 1997; 67: 56-60. (Pubitemid 27433329)